Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Board Committee changes

22 Nov 2023 07:00

RNS Number : 2062U
Johnson Matthey PLC
22 November 2023
Β 

Β 

22nd November 2023

Β 

Johnson Matthey Plc

(the Company)

Board Committee changes

Β 

The Company announces the following changes to the composition of its Board Committees in respect of non-executive directors, effective from 2nd January 2024. These changes align with the Company's overall approach to simplifying the business and enhancing efficiency to deliver its strategic priorities:

Β 

Β· Audit Committee: Xiaozhi Liu and Chris Mottershead will step down as members.

Β 

Β· Remuneration Committee: Barbara Jeremiah and Rita Forst will step down as members.

Β 

Β· Societal Value Committee: Patrick Thomas, Xiaozhi Liu, Chris Mottershead and DougΒ Webb will step down as members.

Β 

As previously announced, Chris Mottershead will step down from the Board on 26th January 2024.

Β 

The Board and Committee membership as at 2nd January 2024 is set out below:

Β 

Board membership

Β 

Patrick Thomas

Liam Condon

Stephen Oxley

Barbara Jeremiah

Rita Forst

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

Β 

Chair

Chief Executive Officer

Chief Financial Officer

Senior Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Board Committee

Β 

Committee Chair

Members

Audit Committee

Β 

Doug Webb*

Β 

Rita Forst

Jane Griffiths

Barbara Jeremiah

John O'Higgins

Β 

Remuneration Committee

John O'Higgins

Jane Griffiths

Xiaozhi Liu

Chris Mottershead

Doug Webb

Β 

Nomination Committee

Β 

Patrick Thomas

Β 

Rita Forst

Barbara Jeremiah

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

Β 

Societal Value Committee

Jane Griffiths

Β 

Liam Condon

Barbara Jeremiah

Rita Forst

John O'Higgins

Stephen Oxley

Β 

Β 

* Audit Committee financial expert

Β 

Β 

This announcement is made in accordance with Listing Rule 9.6.11.

Β 

Β 

ENDS

Β 

Notes

Biographies of each Board member and the Terms of Reference of each Board Committee are available at www.matthey.com

Β 

Enquiries:Β 

Β 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

Β 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered inΒ EnglandΒ &Β WalesΒ number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOANKDBBDBDBADB
Date   Source Headline
18th Nov 20223:51 pmRNSHolding(s) in Company
18th Nov 20223:28 pmRNSDirector/PDMR Shareholding
17th Nov 20224:03 pmRNSHolding(s) in Company
17th Nov 202210:12 amRNSHolding(s) in Company
17th Nov 202210:02 amRNSHolding(s) in Company
11th Nov 20225:17 pmRNSHolding(s) in Company
11th Nov 20229:00 amRNSHolding(s) in Company
4th Nov 20223:16 pmRNSHolding(s) in Company
1st Nov 20225:54 pmRNSHolding(s) in Company
1st Nov 20224:13 pmRNSHolding(s) in Company
1st Nov 20224:11 pmRNSHolding(s) in Company
21st Oct 20224:44 pmRNSHolding(s) in Company
20th Oct 20224:10 pmRNSDirector/PDMR Shareholding
20th Oct 20222:48 pmRNSHolding(s) in Company
13th Oct 202211:29 amRNSHolding(s) in Company
11th Oct 202210:00 amRNSHolding(s) in Company
11th Oct 20227:00 amRNSHolding(s) in Company
30th Sep 20222:56 pmRNSHolding(s) in Company
30th Sep 202212:17 pmRNSHolding(s) in Company
30th Sep 202211:34 amRNSDirector/PDMR Shareholding
29th Sep 202210:18 amRNSHolding(s) in Company
27th Sep 20224:23 pmRNSHolding(s) in Company
26th Sep 20223:35 pmRNSHolding(s) in Company
22nd Sep 20223:38 pmRNSDirector/PDMR Shareholding
20th Sep 20224:31 pmRNSHolding(s) in Company
20th Sep 20223:30 pmRNSDirector/PDMR Shareholding
20th Sep 20222:27 pmRNSHolding(s) in Company
15th Sep 202210:28 amRNSHolding(s) in Company
7th Sep 20229:49 amRNSHolding(s) in Company
2nd Sep 20224:22 pmRNSHolding(s) in Company
1st Sep 20229:42 amRNSTotal Voting Rights
30th Aug 202212:37 pmRNSHolding(s) in Company
30th Aug 202212:26 pmRNSHolding(s) in Company
26th Aug 20229:37 amRNSHolding(s) in Company
25th Aug 20223:19 pmRNSHolding(s) in Company
25th Aug 20222:28 pmRNSHolding(s) in Company
24th Aug 202210:55 amRNSHolding(s) in Company
22nd Aug 202212:20 pmRNSHolding(s) in Company
18th Aug 20223:57 pmRNSDirector/PDMR Shareholding
17th Aug 20224:16 pmRNSHolding(s) in Company
15th Aug 20225:23 pmRNSHolding(s) in Company
15th Aug 202212:39 pmRNSHolding(s) in Company
11th Aug 20223:57 pmRNSDirector/PDMR Shareholding
11th Aug 20223:45 pmRNSDirector/PDMR Shareholding
11th Aug 20228:30 amRNSHolding(s) in Company
10th Aug 20223:53 pmRNSDirector/PDMR Shareholding
9th Aug 20222:31 pmRNSHolding(s) in Company
5th Aug 202211:10 amRNSHolding(s) in Company
3rd Aug 20224:31 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.